PureTech Health (PRTC)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

 120.40p
   
  • Change Today:
      0.000p
  • 52 Week High: 141.20
  • 52 Week Low: 106.40
  • Currency: UK Pounds
  • Shares Issued: 245.18m
  • Volume: 23,142
  • Market Cap: £295.20m
  • Beta: 0.01

PRTC Overview

PureTech Health plc (“PureTech Health”, “PureTech” or “the Company”) is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2114.8% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 84.8 n/a
Pr/Book 1.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

PRTC Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 17.39 (58.95) (21.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 15.62 (92.78) (18.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 3.33 (36.10) (24.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-24 4.66 23.77 21.00¢ 9.7 n/a n/a n/a 0.0%
31-Dec-25 4.66 (110.93) (46.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

PRTC Company Announcements

Total Voting Rights 01-Sep-2026 07:00 RNS
Holding(s) in Company 28-Aug-2026 07:00 RNS
PDMR Notification RSU Vesting 18-Aug-2026 17:30 RNS

PRTC ShareCast News

PureTech appoints Robert Lyne as permanent CEO 18-Dec-2025 ShareCast
PureTech Health contract revenues surge, cuts co... 28-Aug-2025 ShareCast
PureTech launches respiratory development vehicl... 12-Aug-2025 ShareCast

Latest PRTC Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

PRTC Market Data

Currency UK Pounds
Share Price 120.40p
Change Today 0.000p
% Change 0.00 %
52 Week High 141.20
52 Week Low 106.40
Volume 23,142
Shares Issued 245.18m
Market Cap £295.20m
Beta 0.01

PRTC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
49.17% above the market average49.17% above the market average49.17% above the market average49.17% above the market average49.17% above the market average
95.12% above the sector average95.12% above the sector average95.12% above the sector average95.12% above the sector average95.12% above the sector average
Price Trend
53.88% below the market average53.88% below the market average53.88% below the market average53.88% below the market average53.88% below the market average
Sector averageSector averageSector averageSector averageSector average
Income Not Available
Growth
23.61% below the market average23.61% below the market average23.61% below the market average23.61% below the market average23.61% below the market average
37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average37.93% below the sector average

PRTC Dividends

No dividends found

Trades for 02-Sep-2026

Time Volume / Share Price
08:37 311 @ 120.40p
08:37 858 @ 120.40p
08:31 2,887 @ 120.38p
08:30 202 @ 120.80p
08:23 599 @ 120.00p

PRTC Key Personnel

CEO Robert Lyne

Top of Page